Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sun Pharma Advanced Research Co. Ltd. ( (IN:SPARC) ) just unveiled an announcement.
Sun Pharma Advanced Research Company Limited has called an extraordinary general meeting (EGM) of its shareholders on 9 February 2026, to be held via video conferencing, with remote e-voting scheduled between 5 and 8 February 2026. The key agenda item is a special resolution to approve the issue of convertible warrants on a preferential basis to a member of the company’s promoter group, a move that, if approved, would strengthen the company’s capital base, potentially increase promoter stake, and support future funding needs for its research-driven growth strategy, while also requiring compliance with a range of Indian corporate, securities, and foreign exchange regulations.
More about Sun Pharma Advanced Research Co. Ltd.
Sun Pharma Advanced Research Company Limited (SPARC) is a pharmaceutical research and development company focused on advancing innovative drug delivery systems and specialty pharmaceuticals. Headquartered in Gujarat, India, SPARC operates as an innovation-driven arm within the broader Sun Pharma ecosystem, targeting complex therapies and value-added formulations for global markets.
Average Trading Volume: 566,586
Technical Sentiment Signal: Sell
Current Market Cap: 43.96B INR
Find detailed analytics on SPARC stock on TipRanks’ Stock Analysis page.